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ABSTRACT:
Lymphatic filariasis (elephantitis) is a disfiguring disease caused by thread-like
nematodes. This disease affects the lives of over 120 million people and over one billion
people are at risk for infection in endemic regions. Drugs used to treat this disease suffer
from toxicity and emerging resistance and new therapies need to be identified. Our
laboratory has been studying the filarial parasite, Brugia malayi (B. malayi), one of the
causative agents of this disease. The laboratory is focused on the study of critical protein
kinase signaling pathways, necessary for parasite protective anti-oxidative responses, as
potential therapeutic targets. We have previously determined, using a bioinformatic and
chemical biological approach that the B. malayi stress-activated protein kinase, BmMPK1, plays a critical role in defense against reactive oxygen species (ROS) stress
generated by the innate immune system. The first part of my thesis extends our previous
observation by examining the role of Bm-MPKl in protection against reactive nitrogen
„ species (RNS) which are also generated by the innate immune system during infection. I
have found that treatment of the adult parasites with the Bm-MPKl inhibitor, BIRB796,
in the presence of RNS, leads to a reduction in parasite viability. These results implicate
Bm-MPKl in a protective signaling pathway against both ROS and RNS.
The second part of my thesis explores the generality of the use of bioinformatics,
comparative genomics and chemical biological approaches for the identification of
potential parasitic protein kinase targets. Using genomic data for the nematode
Caenorhabditis elegans (C.elegans) and B. malayi, I have identified B. malayi Src kinase
as a potential drug target. Treatment of adult B. malayi parasites with the clinically

approved human Src inhibitor dasatinib (Sprycel®), leads to decreased viability and
defects in embryogenesis similar to those seen in C. elegans Src genetic knockdowns.
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INTRODUCTION:

I.

Lymphatic Filariasis

Lymphatic filariasis (elephantitis) is a disfiguring disease caused by the thread-like
nematodes Brugia malayi, Brugia timori and Wuchereria bcincrofti. This disease affects
the lives of over 120 million people and over one billion people are at risk for infection
[1,2]. The majority of lymphatic filariasis is caused by W bancrofti and is prevalent in
the tropics. B. malayi is found in South Asia and B. timori in Timor and the Flores areas
of Indonesia [1]. Unlike W. bancrofti and B. timori, B. malayi can infect mammals such
as gerbils and cats providing an animal model for the disease.
In this disfiguring disease, the human plays the role as the host and the mosquito,
Mansonia spp, the vector. Upon taking a blood meal, the mosquito picks up microfilaria,
the immature stage of the parasite, present in the human host. These ingested
microfilaria mature to the third stage larvae form (L3) and migrate to the head and
proboscis of the mosquito. During the next blood meal, the L3 larva are transmitted into
the human host and travel to the efferent lymphatics and subcapsular sinus. The parasite
will mature to the adult stage within 6 to 12 months. Females will produce
microfilariae after mating males, completing the life cycle of this organism.
Microfilariae in an infected human can be detected within 41 to 46 weeks post infection.
Adult parasites have a life span of several years within the host [3] (Figure 1).
Current treatment for lymphatic filariasis is targeted against the microfilaria. A popular
macrocyclic lactone, ivermectin (Mectizan®), is used to treat lymphatic filariasis. It has
been shown that ivermectin inhibits L3 molting and reduce microfilariae output by

sterilizing the female adults [4]. Ivermectin targets the glutamate-gated Cl" and K+
channels of nematodes which causes paralysis of the body wall muscle, including the
pharynx [1]. Another drug, diethylcarbmazine (DEC), dramatically reduces microfilarial
count in the blood within a few minutes. In rodent models, it has been demonstrated that
DEC acts on microfilariae by unmasking antigenic determinates that facilitate killing of
the organism by kupffer cells of the reticuloendothelial system [4]. It has also been found
that inducible nitric oxide is essential for DEC activity against microfilaria [5]. DEC was
the most popular drug to treat the disease, however the microfilaricidal ivermectin has
been shown to have fewer side effects [6]. A third drug, albendazol, considered an
effective and safe drug for treating intestinal helminthes, is commonly co-administered
with either ivermectin or DEC. It has been proven to have long-term effectiveness in
decreasing microfilaria in W. bancrofti infections. However, there is insufficient
evidence that co-administration of albendazol with ivermectin and DEC provides any
advantage over these drugs alone [1]. New drugs are needed due to emerging issues with
toxicity and resistance with currently used drugs. [7, 8].
Our laboratory has been focused on parasitic protein kinases as potential drug targets.
We have previously determined that a parasitic ortholog, Bm-MPKl, of human p38
mitogen activated protein kinase (p38) and C. elegans PMK-1 protein kinase is required
for parasite protective responses against oxidative stress [9]. My thesis research extends
this work to include stress due to reactive nitrogen species (RNS). In addition, using a
comparative genomics and chemical biological approach, I have identified a B. malayi
Src tyrosine kinase as a potential drug target.
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II.

Filarial Parasites and Oxidative Stress

Resistance of filarial nematodes to oxidative stress is essential to long term survival
inside the human host. These parasites must protect themselves from host innate immune
responses which produce reactive oxygen and nitrogen species such as superoxide and
nitric oxide. Filarial parasites have a number of mechanisms which protect the parasite
against oxidative stress [10, 11]. One important mechanism has been identified in our
laboratory. Our lab has identified a B. malayi protein kinase, Bm-MPKl, which plays a
crucial role in protection against oxidative stress [9]. Interestingly, Bm-MPKl is an
ortholog of the human p38 stress-activated mitogen-activated protein kinase family.
The p38-stress activated protein kinase family
Mammalian cells respond to stress such as UV, inflammatory and oxidative stress
through the activation of stress activated protein kinases. There are two families of
stress-activated protein kinases, the C-terminal JUN kinases (JNK), and the p38 mitogenactivated protein kinase family. A stress stimulus from the environment leads to the
activation of a protein kinase cascade initiated by a mitogen activated kinase kinase
kinase (MKKK), which in turn phosphorylates a mitogen activated kinase kinase (MKK).
MKK dually phosphorylates JNK and p38 on a conserved T-X-Y motif leading to
activation of JNK and p38 which in turn, produces a biological response. [12]. This
thesis will focus on the p38 MAPK family and its relationship to Bm-MPKl.
The p38 MAPK family consists of the four isoforms, p38a, p38f3, p38y, and p385 which
share 60% homology overall. The p38a and p38(3 isoforms share 75% homology overall
[13]. It has been observed that p3 8a is the predominant form in monocytes and

macrophages [14], p38y is most significantly expressed in skeletal muscle and p385 is
found mostly in the testis, pancreas, kidney and small intestine [13].

Human p38a and

P was originally identified as the molecular target of the pyridinyl class of compounds
that were shown to inhibit the biosynthesis of inflammatory cytokines such as tumuor
necrosis factor (TNF) in lipopolysaccharide (LPS)- stimulated human monocytes [15].
Activation of p38 is shown to occur in response to T cell antigen receptor (TCR)
signaling and participates in thymocyte development, differentiation of T helper type 1
cells and activation of mature T cells in response to antigen. In addition to the activation
of the p38 family in response to stress such as hyperosmolarity, UV irradiation and heat
shock p38 signaling is also important for cell survival, apoptosis and induction of
cytokine genes. Activation of p38 occurs by dual phosphorlylation of Thr-180 and Try182 in a TGY motif by MKK3/6, and MKK4 in some cases [12]. The TGY motif is
located within a regulatory loop between subdomains VII and VIII. As a result of
phosphorylation, a conformational change occurs which enables ATP and substrate to
bind the kinase.

The duration of phosphorylated p38 is controlled by phosphatases such

as protein phosphatase 1, protein phosphatase 2A or MAPK phosphatase [16].
Substrates for active p38 include transcription factors ATF2, Elk-1 and SAP1 and kinases
MAPKAP-K2 and MAPKAP-K3 [13].
In view of the therapeutic importance of p38 (i.e. in inflammation and oncology)
numerous programs have been established to identify selective and potent inhibitors of
p38. One of the first inhibitors developed is the prototypic pyridylimidazole SB203580 is
a competitive inhibitor of p38 (Figure 2). SB203580 has been used as a template for a
vast majority of p38 inhibitors [14]. This compound inhibits of the p38a and p38(3
4

isoforms, but not the p38y or p385. SB203580 prevents ATP binding through the
interaction of its fluorine atom with Thrl06 of the kinase. The drug is oriented with
His 107 and Leul08 of the ATP pocket [13]. Inhibitors such as SB202190 and VX702
are also competitive for the ATP substrate.
Novel classes of allosteric inhibitors have recently been developed. BIRB796 is an
allosteric diaryl urea inhibitor that can bind to all four isoforms (Figure 3). This
compound binds with a slow on rate to p38 to a site spatially distinct from the ATP
pocket. A conformational change occurs on a highly conserved DFG motif upon binding
of BIRB796 which prevents ATP binding to its designated pocket. The apparent IC50 of
BIRB796 against p38 decreases with incubation time with kinase and inhibitor, with an
IC50 of 98 nM at 0 h and 8 nM at 2 h [17].
PMK-1 and Bm-MPKl MAPKs and oxidative stress
The roundworm C. elegans is a powerful model system for the study of numerous
biological systems. Its genome has been sequenced and annotated and can be accessed at
www.wormbase.org. The C. elegans stressed-activated protein kinase, PMK-1 is an
ortholog of human p38 [9]. It has been determined through genetic means, that PMK-1 is
essential for innate immunity and protection against oxidative stress in C. elegans. [1820] PMK-1 phosphorylates and activates the transcription factor SKN-1 leading to the
induction of phase II detoxification gene expression [19]. We have found that PMK-1 is
an ortholog of the B. malayi kinase Bm-MPKl mentioned previously. Using a chemical
biological approach, we demonstrated that inhibitors of human p38 inhibit the activity of
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Bm-MPKl leading to the inability of parasites to respond to oxidative stress
compromising parasite viability [9].
The role of nitric oxide and peroxynitrite in oxidative stress
In addition to ROS, the generation of reactive nitrogen species (RNS) such as nitric oxide
are produced by the innate immune system. Nitric oxide (NO) plays an important role in
human biology. Free NO is a small molecule radical (ti/2 = ~5 seconds [21]) that can
easily permeate cell membranes. At low concentrations, it is known to be a vasodilator
and results in an increase in the flow of blood through vessels by smooth muscle
relaxation. NO is produced by the enzymatic activity of nitric oxide synthase (NOS)
which oxidizes the guanidine group of L-arginine (Figure 4). The reaction requires the
cofactor tetrahydrobiopterin, BH4, and the additional reactants O2 and NADPH. High
levels of nitric oxide are generated during inflammation and can modify and damage
DNA, RNA, lipids and proteins [22]. There are three known isoforms of NOS; neuronal
(nNOS), epitheial (eNOS) and inducible (iNOS). Macrophages possess the iNOS
isoforms and generate NO as part of their biochemical defense against foreign pathogens
[23].
Peroxynitrite is a damaging reactive nitrogen species (RNS) that is produced by the
interaction of NO with superoxide (CV). It is a short lived compound that has a higher
permeability than superoxide. Peroxynitrite has the ability to inhibit Mn superoxide
dismutase by nitration of a critical Tyr-34 residue. This allows an increase in the amount
of superoxide and hydrogen peroxide which increases damage to mitochondria.
Peroxynitrite produces the following cytotoxic effects: initiation of lipid peroxidation,
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direct inhibition of mitochondrial respiratory chain enzymes, inactivation of membrane
sodium channels, inactivation of glyceraldehydes-3-phosphate dehydrogenase, and
inhibition of membrane Na+/K+ ATP-ase activity. [24].
The role of the B. malayi stress-activated protein kinase, Bm-MPKl, in RNS has not been
evaluated. In order to study the effects of RNS-induced stress, the compound
linsidomine chlorhydrate (SIN-1) was used to mimic this stress. SIN-1 undergoes auto
oxidation to produce NO and O2 "(Figure 5), which subsequently lead to the formation of
peroxynitrite. The first part of this thesis will evaluate the role of Bm-MPKl in antiRNS stress.
III.

Application of Bioinformatics and Chemical Biology to filarial
parasite drug target discovery

Protein kinases are one of the largest and most important of the protein families
accounting for ~2% of the genes in a variety of eukaryotic genomes. Protein kinases are
important therapeutic targets [25]. The Bcr/Abl kinase inhibitor imatinib (Gleevec ®), is
the first targeted cancer therapy used clinically to treat chronic myelogenous leukemia
and gastrointestinal stromal tumors. Kinases phosphorylate other proteins in the cell,
which modifies the activity, location and the affinities of nearly 30% of all cellular
proteins at any given time. They direct signal transduction and coordination of complex
pathways, many of which are highly conserved between different species.
Bioinformatics and comparative genomics have been shown to be powerful tools in
analyzing the evolutionarily conserved function of kinases. Nematodes share 153 kinase
subfamilies with humans, and provide orthologs for 81% (419/518) of all human kinases.
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Some of these human orthologs have selective synthetic inhibitors which can potentially
be used to elucidate signaling pathways in nematodes [26].
The NIAID/NIH Filariasis Research Reagent Resource Center (FR3) provides a database
on their website that correlates C. elegans genes with putative B. malayi homologs. A
total of 4,620 C. elegans genes having B. malayi orthologs are listed, of these, 2,547
orthologs are listed having the corresponding C. elegans RNAi knockdown phenotypes.
A database of the C. elegans kinome (www.kinase.com) lists 438 protein kinase genes.
The B. malayi kinome contains 225 kinase genes [27]. Using this database and the FR3
database allows a comparison of protein kinase orthologs between C. elegans and B.
malayi along with RNAi phenotypic annotation. The use of RNAi on the adult B. malayi
parasite has met with very little success largely due to the absence of genes in the parasite
required for RNA uptake and distribution [28, 29]. One approach to potentially
overcome this limitation to studying protein kinase function (i.e. through RNAi
knockdowns) is to compare protein kinase orthologs between C. elegans and B. malayi
and identify those kinases exhibiting a critical phenotype and for which specific
inhibitors against human orthologs exist. It may therefore be possible to examine the
effects of treating B. malayi parasites with specific inhibitors and comparing the resulting
phenotypes with the C. elegans RNAi knockdowns. Presented in this thesis are the results
of using a commercially available Src tyrosine protein kinase inhibitor to compare the
phenotypes between inhibitor treated parasites and the corresponding C. elegans RNAi
knockdown.
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MATERIALS AND METHODS

Immobilized Metal Affinity Ion Polarization Assay (IMAP)

The following compounds were previously assayed for potency against Bm-MPKl in the
lab: BIRB796 (Axon Groningen, Netherlands), SB203580 (Selleck, Houston, TX),
RWJ67657 (Dr. Fina Liotta, Montclair State University).

Additional p38 inhibitors

SB202190 (BIOMOL/Enzo Farmingdale, NY) and VX702 (Selleck) were assayed
against Bm-MPKl for this thesis.

All inhibitors were first dissolved in dimethyl

sulfoxide (DMSO) at a 10 mM concentration. Inhibitors were assayed for potency using
an IMAP assay (Molecular Devices; Sunnyvale, California). IMAP is a high-throughput
fluorescent based assay suitable for high-throughput screening. A kinase reaction was
performed by adding enzyme, a fluorescent substrate (peptide) and ATP for an incubation
of 1 h.

The reaction was terminated by the addition of a nanoparticle suspension

containing a coupled trivalent metal ion (Mm) which binds to the phosphorylated peptide
product. The binding of the

metal ion to the phosphorylated fluorescent substrate

generated molecules with a slower rotational speed and thus increased the Fluorescence
polarization (FP) signal [30].
Active Bm-MPKl was generated as described in our recently published paper [9].
The IMAP assay was conducted as per manufacturer’s instructions (Molecular Devices).
Activated Bm-MPKl, inhibitor and the fluorescent peptide, FAM-p38tide (Molecular
Devices) were prepared in 1 mM dithiothreitol (DTT) (Fisher Scientific), 100 pM ATP
(Sigma-Aldrich), IX Reaction Buffer-Tween (10 mM Tris-HCl pH 7.2, 10 mM MgCl2,
0.05% NaN3 and 0.01% Tween-20) buffer (Molecular Devices). Inhibitor concentrations
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were serially diluted starting from 10,000 nM to 14 nM. The kinase reaction was initiated
by using 60 ng of active Bm-MPKl, 100 nM fluorescent substrate and inhibitor which
was allowed to incubate at room temperature for 1 h on a plate shaker (Bamstead/Labline). All kinase reactions were performed at a volume of 20 pL in a low volume black
96-well plate (Coming Lowell, MA). After the 1 hour incubation, the reaction was
terminated with the addition of 60 pL of PBB containing the nanoparticles (1:600)
prepared as per manufacturer’s instmctions (Molecular Devices).

An additional

incubation period of 1 h was performed and the plate was read using Synergy 2
microplate reader. The plate was read using an excitation wavelength of 485 nm and an
emission wavelength of 528 nm [30]. The plate consisted of background containing
substrate and ATP and a max with Bm-MPKl, peptide and ATP. The data was analyzed
in Microsoft Excel, and was corrected for background.

IC50 values were calculated

based on a four parametric logistic fit in Microsoft Excel using Solver.
Motility o f B. malayi Adult Parasites
Female adult B. malayi parasites were procured from the NIAID/NIH Filariasis Research
Reagent Resource Center (FR3) at the University of Georgia. Parasites were placed on
24 well plates (BD Franklin Lakes, NJ) in 2 mL of complete media and allowed to rest
for 24 h. Media consisted of Advanced RPMI 1640 (Invitrogen, Carlsbad, CA)
supplemented with 25 mM HEPES, L-Glutamine, Penicillin-Streptomycin (Invitrogen),
Amphotericin B solution (Invitrogen), 5% heat inactivated fetal bovine semm (FBS)
(Invitrogen). Adult parasites were then cultured in complete media supplemented with
the desired concentrations of SIN-1 (Invitrogen), dasatinib (ChemieTek; Indianapolis,
Indiana) or BIRB796 (Axon). Motility of each adult was examined every 24 hours.
10

Parasite motility was given a score from 0 to 4 with: 4, rapid movement and largely
coiled; 3, moderate movement and uncoiled; 2, slow movement and uncoiled; 1,
twitching movement and uncoiled; 0, no motility (dead).
SDS Page/Western Blotting o f active Bm-MPKl RNS-induced stress

The effect of RNS-induced stress was examined by Western blotting probing against
pTGpY. Six adult worms were used per treatment group. The combination of SIN-1
and BIRB796 was pretreated with BIRB796 for 1 h. After 1 h of exposure, extracts of the
adults were made by motar and pestle in a solution containing M-PER (Thermo
Scientific) with phosphatase inhibitor (10 mM sodium fluoride, 2 mM pyrophosphate, 2
mM Beta-glycerol phosphate and 5 g/ml). Protein content was measured by Bradford
assay (Sigma-Aldrich; St. Louis, M O,) [31] with BSA as the standard. Twenty-six
micrograms of protein from each treatment was loaded on to an SDS-PAGE (Table 2).
Samples of each treatment group were prepared in NuPAGE SDS sample buffer
(Invitrogen) containing DTT and placed in a heating block at 90°C for 5 minutes. The
samples were loaded on a 10-well NuPAGE 4-12% Bis-Tris 1.0 mm gel (Invitrogen) and
were run at 200 V for 40 minutes using MOPS SDS running buffer (Invitrogen). Novex
sharp pre-stained protein standards (Invitrogen) were loaded on the gel as molecular
weight markers. The gel was transferred onto a PVDF membrane, previously soaked in
methanol for 30 sec, using NuPAGE® Transfer Buffer (Invitrogen) containing 10%
methanol and 0.25% SDS using a TE77XP Semi-DryBlotter (Hoefer Holliston,MA) for 1
h at 54 mA. The membrane was incubated with rabbit Anti-Active® (pTGpY) affinity
purified polyclonal IgG antibody 1:2000 (Promega, Madison, WI) for 1 h and incubated
with alkaline phosphatase (AP)-linked secondary antibody 1:30,000 anti-rabbit (Sigma11

Aldrich). Chromogenic Western Blue® Stabilized Substrate for AP (Promega) was added
to the membrane for the elucidation of active, phosphorylated Bm-MPKl bands.
Densitometry was analyzed using Image-J program [32].
Screening o f Kinase Inhibitors against B. malayi based on the C. elegans kinome

Data was downloaded from the databases from both the FR3 website
(http://www.filariasiscenter.org) and Kinase.com (www.kinase.com) regarding C. elegans
RNAi knockdowns and their corresponding kinases. A query was performed through
Microsoft Access on the two databases that matched the corresponding genes from the C.
elegans RNAi knockdowns data with the corresponding B. malayi orthologs that translate
protein kinases. This was performed by creating a table for each database and linking
each table by the C. elegans ortholog accession number.
Evaluation o f Dasatinib on B. malayi parasites

Screening of the kinase inhibitor on the B. malayi parasite was performed similarly as
stated in the section Motility o f B. malayi Adult Parasites. Parasites were transferred into
fresh media every 48 h. Parasite secretions of microfilaria were monitored every 24 h
during the course of the experiment.
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RESULTS

p38 inhibitor evaluations against Bm-MPKl

Several commercially available p38 inhibitors were previously tested against p38 and
Bm-MPKl. I evaluated an additional two new inhibitors, SB202190 and VX702. The
IC50 values for SB202190 and VX702 were determined to be 220 and 4,270 nM
respectively as determined by two separate assays. Interestingly, VX702 is a potent
inhibitor of human p38 exhibiting an IC50 of 4.0 nM, 1068 times less potent against BmMPKl. This suggests that the inhibitor binding site differs significantly between humans
and B. malayi potentially allowing the design of more selective Bm-MPKl inhibitors.
Based on its potency and prior use studying ROS-induced stress, I used BIRB796 to
evaluate the role of Bm-MPKl in RNS-induced stress (Figure 6 , Table 1).
Effect o f BIRB796 on RNS-induced stress in Adult B. malayi Parasites
A titration of SIN-1 indicated that 0.250 mM is the optimal concentration to perform
RNS-induced stress experiments without any overt effects on parasite viability. Similarly,
we have previously observed that using 10 pM BIRB796 with the parasites does not
affect viability [9]. Upon treatment of parasites with the combination of 0.250 mM SIN1 and 10 pM BIRB796, parasite motility was significantly reduced at 24 h (25% of
control) and 48 h (50% of control) (Figure 7). Decreases in the motility of parasites
correspond to decreased viability [33].
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Activation o f Bm-MPKl by SIN-1 and inhibition by BIRB796

Bm-MPKl was activated in vivo under conditions of RNS-induced stress. Western
blotting of adult worm extracts exposed to 0.250 mM SIN-1 for 1 hour revealed a band at
~42 kDa when probed with anti phosphor p38 ( pTGpY) antibodies. These antibodies
only bind to the phosphorylatd form of Bm-MPKl. A 4 fold increased in phosphorylated
Bm-MPKl was observed when compared to control. An approximate 50% reduction in
activated Bm-MPKl was observed upon the addition of 10 pM BIRB796 when compared
to 0.250 mM SIN-1 alone (Figure 8 A, B). These experiments demonstrate activation of
Bm-MPKl within the parasite upon SIN-1 treatment and subsequent inhibition in the
presence of the p38 inhibitor BIRB796.
Bioinformatic analysis o f the B. malayi and C. elegans kinomes. Use o f the src kinase
inhibitor dasatinib as a chemical probe.

A total of 435 kinases are present in C. elegans, whereas approximately half this number,
225 are present in B. malayi (Figure 9) [27]. A query performed using Microsoft Access
provided a list of 77 C. elegans protein kinases serving critical functions (as determined
using RNAi knockdown technology) having orthologs in B. malayi. (Figure 10, Table 3).
Twelve of these kinases have commercially available inhibitors. It was decided to focus
on src kinase since RNAi knockdowns in C. elegans exhibited sever defects in
embryogenesis and locomotion. In addition, a selective src inhibitor, dasatinib, is
commercially available as a chemical probe.
Treatment of parasites with 10 pM dasatinib induced sever locomotion defects within
three hours. All treated parasites curled up into a corkscrew like conformation as
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opposed to the normal extended conformation (Figure 10 A, B). These parasites returned
to their previous extended confirmation when examined at 24 h, but exhibited a 50%
reduction in motility compared to the control group (Figure 11). No effects were
observed with 1 pM dasatinib. Further evaluation was not possible beyond 72 hours due
to a reduction in control group motility. It was observed that the secretion of microfilaria
was significantly reduced with 10 ¡iM dasatinib treatment in the first 24 hours onward
compared to the control group. By 96 h, virtually no secretion was observed. Dissection
of control group parasites revealed relatively equal distribution of microfilaria,
premicrofilaria and early stage embryos (Figure 12), whereas a dissection of adult
parasites exposed to 10 pM dasatinib for 96 h had a distribution of mostly early stage
embryos and premicrofilaria (Figure 13). Additionally, early stage embryos from the 10
pM dasatinib group appeared morphologically abnormal when compared to the control
group (Figure 14 A, B).
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DISCUSSION

Bm-MPKl and its role in RNS-induced stress

A common finding in both protozoan and helminthic infections is the production of NO
by cells of the innate immune system. Elevation of NO has been confirmed in human
patients infected with B. malayi. It is believed NO is produced through the induction of
iNOS in the direct response of the host’s innate immune system to the parasite antigens
or possibly due the endotoxin derived from the endosymbotic bacteria, Wolbachia,
present in the nematode [34] . In this thesis, I have demonstrated that the B. malayi p38
ortholog, Bm-MPKl, is sensitive to the effects of RNS induced stress through the use of
the NO donor SIN-1. At sub-optimal, no-effect doses of SIN-1 (0.250 mM), treatment
of parasites with the Bm-MPKl inhibitor, BIRB796, renders the parasites sensitive to
RNS leading to a significant reduction in motility and viability within 24-48 h of
treatment. These results show that RNS, like ROS, leads to activation of Bm-MPKl as
part of an anti-stress response. Inhibition of Bm-MPKl with BIRB796 leads to an
increased susceptibility of the parasite to the effects of RNS and ROS and compromises
viability. RNS stress has been shown to lead to the activation of p38 in mammalian cells
as part of an anti-stress response [35, 36]. Similarly, I have shown in this thesis that BmMPKl is activated 4- fold in parasites treated with 0.250 mM SIN-1 and is inhibited by
50% with the addition of 10 pM BIRB796.
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Drug Target Discovery: Use o f Bioinformatics and Comparative Genomics with
Chemical Biological Approaches to study Parasite Protein Kinase Signaling Pathways

The study of filarial parasite biology and biochemistry suffers from a lack of genetic
techniques to study gene function. As mentioned previously, techniques such as RNAi
knockdowns which offer a powerful tool in studying C. elegans biology, have met with
poor results in filarial nematodes. To circumvent this problem, we have been combining
bioinformatics and chemical biological approaches to study protein kinase signal
pathways in B. malayi. A successful example of this approach can be found in our recent
research with the B. malayi stress-activated protein kinase Bm-MPKl. This kinase was
identified as a human p38 and C. elegans PMK-1 ortholog through database blast
searches. Examining the results of PMK-1 knockdown studies in WormBase, it was
found that PMK-1 is required for C. elegans innate immunity and protection against
arsenate-induced oxidative stress [18-20]. Using selective p38 inhibitors, we
demonstrated that inhibition of Bm-MPKl with the allosteric inhibitor, BIRB796, leaves
B. malayi susceptible to arsenate-induced stress in a manner similar to that observed in C.
elegans RNAi knockdowns of PMK-1 [9].
To further extend the generality of this approach, I identified 77 proteins kinases with
critical functions in C. elegans that have orthologs in B. malayi. Twelve of these kinases
have commercially available inhibitors, which includes the p38 ortholog Bm-MPKl. I
choose the B. malayi src protein kinase as a target and used the human src inhibitor
dasatinib, as a chemical biological probe to study the function of B. malayi src.
Dasatinib, at a concentration of 10 |iM, produced defects in viability, embryogenesis and
microfilaria secretion in the adult B. malayi parasite. These phenotypes mirror those
17

reported using RNAi knockdown approaches for the src-1 gene in C. elegans which
include defects in embryogenesis and locomotion.
In summary, I have shown that combining bioinformatics and chemical biology can be a
useful tool for studying protein kinase function in the parasitic nematode B. malayi.
Through the use of selective kinase inhibitors, the phenotypes observed in C. elegans
RNAi knockdown studies can be recapitulated with synthetic inhibitors in B. malayi. The
use of selective, small molecule, inhibitors to study other parasitic protein functions, e.g.
metalloproteinases, GPCRs, etc. warrants consideration.
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Figure 1. The life cycle of the filiarial nematode B. malayi
The B. malayi parasite uses the mosquito Mansonia spp. as a vector to invade the human
host. An infected mosquito will inject the third stage larval form of the parasite up blood
feeding. The L3 will progress to the adult stage in the lymphatic system of the human.
Upon mating, females will produce the immature larval stage, the microfilariae, and
secrete them into the blood stream of the human during night time. An uninfected
mosquito will ingest the microfilaria during a blood feeding, where the infectious L3
larva form will develop and continue the cycle of infection.
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Figure 2. Structure of the competitive inhibitor SB203580 (Sigma).

Figure 3. Structure of the allosteric p38 inhibitor BIRB796 (Axon).

NK9

NHL

I
t
m

*

»

HOOP“ OH
I
L-Arginine

i d
0=0

nadph nmp*

1
UH
I

3

NOSymtase

HOX“ CM

4* NO"

a1

*mÈ
L^Clfrulne
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20

\

'

.... .....................

'■. ,

4
NO' - H

Figure 5. The structure of SIN-1 and its auto-oxidation for the production of NO
and 02*' (www.invitrogen.com).

Figure 6. Dose response curves of BIRB796, SB202190 and VX702 against BmMPK1. The IC50 values of BIRB796, SB202190 and VX702 are 152, 220 and 4,270 nM
respectively.
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Figure 7. Percent control of motility with RNS-induced stress on female adult B.
malayi within 48 h. The data was evaluated as % of control where a motility of 4 was
100% in the experiment and 0% was a 0 motility score. Bars equal to one Standard Error
(SE) n = 6 adult worms per condition. * = p<0.0001
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Figure 8. In vivo activation and inhibition of Bm-MPKl. (A) Western blot was
developed using anti-phospho-p38 Rabbit pAb. Each lane was loaded with 26 pg of
protein. The treatment group of SIN-1 + BIRB796 was pretreated with BIRB796 for 1
h. (B) The representative pixel intensity of the scanned western blot using Image-J. The
pixel intensity was averaged from three separate measurements. Bars equal to one (SE).
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Figure 9. The kinomes of C. elegans and B. malayi share 141 kinases. A total of 435
kinases are present in C. elegans and 225 in B. malayi. Seventy seven of the 141 shared
kinases exhibit detrimental phenotypes.

A)

B)

Figure 10. Conformational differences in 10 pM dasatinib treatment group. A) The
typical elongated conformation of the B. malayi parasite. (Scientific Frontline) B) The
worm shows a "corkscrew” like conformation as oppose to being elongated.
Magnification is at 40x.
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Figure 11. Effects of dasatinib on adult female B. malayi motility. The data was
evaluated as % of control where a motility of 4 was 100% in the experiment and 0% was
a 0 motility score. Bars equal to one Standard Error (SE) n = 5 to 6 adult worms per
condition. * = p<0.0001
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Figure 12. The dispersion of microfilaria (mf), premicrofiliaria (pmf) and early
stage embryos (emb) in the control 0.1% DMSO group. Picture was taken at 50x
magnification.
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Figure 13. The dispersion of microfilaria (mf), premicrofilaria (pmf) and early stage
embryos (emb) in the 10 pM dasatinib treatment group. Picture was taken at 50x
magnification.
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Figure 14. The phenotypical effects of 10 pM dasatinib on early stage embryos in B.
malayi. A) Control 0.1% DMSO treatment group B) 10 pM dasatinib treatment group.
Picture was taken at 200x magnification.
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TABLES

Compound Name
BIRB796
SB202190
SB203580
VX702
RWJ67657

IC50(nM)
Human p38
Bm-MPKl
152
30
17
220
249
15
4,270
3
4
123

Ratio (Bm-MPKl/Human p38)
5
13
17
1,420
28

Table 1. IC50values of p38 inhibitors against p38 and Bm-MPKl. The values for
human p38 were evaluated previously in the lab.

Samples:
Control 0.1% DMSO
10 pM BIRB796
0.250 mM SIN-1
0.250 mM SIN-1 + 10 pM BIRB796

Concentration
Pg/Pl
4.20
5.08
6.88
5.73

Table 2. Crude extracts recovered from adult B. malayi parasites. Protein
concentrations were measured by Bradford Assay. BSA was used as the standard.
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ABSTRACT
Filariasis, caused by thread-like nematode worms, affects millions of individuals throughout the tropics
and is a major cause of acute and chronic morbidity. Filarial nematodes effectively evade host immunolog
ical responses and are long lived within their hosts. Recently an emphasis has been placed on enzymatic
and non-enzymatic anti-oxidant systems which counteract the generation of reactive oxygen species
(ROS) by macrophages and granulocytes, a first line of defense against parasites. We have characterized
an anti-oxidant pathway in the filarial parasite Brugia malayi related to the evolutionarily conserved
human mitogen-activated p38 protein kinase and the Caenorhabditis elegans PMK-1 protein kinase stress
pathways. We have expressed a recombinant p38/PMK-l ortholog from B. malayi (Bm-MPKl) and have
successfully activated the kinase with mammalian upstream kinases. In addition, we have demonstrated
inhibition of Bm-MPKl activity using a panel of known p38 inhibitors. Using the potent and highly selec
tive allosteric p38 inhibitor, BIRB796, we have implicated Bm-MPKl in a pathway which offers B. malayi
protection from the effects of ROS. Our results, for the first time, describe a stress-activated protein kinase
pathway within the filarial parasite B. malayi which plays a role in protecting the parasite from ROS. Inhi
bition of this pathway may have therapeutic benefit in treating filariasis by increasing the sensitivity of
filarial parasites to ROS and other reactive intermediates.
Published by Elsevier B.V.

1. Introduction
Pathogenic filarial nematodes affect the lives of over 120 mil
lion people and place over one billion people at risk of infection
[1,2]. Filarial diseases have a significant economic and psychosocial
impact in endemic areas, disfiguring and incapacitating millions of
individuals. The filarial parasites that pose the most serious pub
lic health threats are Wuchereria bancrofti, Brugia malayi and Brugia
timori, the causative agents of lymphatic filariasis (elephantiasis), as
well as Onchocerca volvulus and Loa loa, the causative agents of sub
cutaneous filariasis (e.g. river blindness). In spite of some success
in treating filiarial diseases with Mectizan® (ivermectin), albenda
zole, and diethylcarbamazine, there is a need for new drugs. Current
drugs target the immature stages (microfilariae) but not the longlived adult worms. There is also significant toxicity associated with
using these drugs and drug resistance is emerging [3,4]. Identifica
tion of new therapeutic agents for the treatm ent of filarial disease
requires a better understanding of filarial homeostasis and critical

* Corresponding author. Tel.: +1 973 655 3411; fax: +1 973 655 7772.
E-mail address: siekierkaj@mail.montclair.edu (J.J. Siekierka).
0166-6851/$ - see front matter. Published by Elsevier B.V.
doi:10.1016/j.molbiopara.2010.12.008

parasite biochemical pathways amiable to drug targeting, an effort
greatly enhanced with the sequencing of the B. malayi genome [5].
Our laboratory has been studying protective responses to oxida
tive stress in the filarial parasite B. malayi. Filarial and other
parasites exhibit a number of defense mechanisms permitting the
parasite to establish infection in the presence of host immune
responses, allowing for long term survival within the host [6-9].
One response used by the host to thw art infection is the genera
tion of reactive oxygen species (ROS) by macrophages, neutrophils,
eosinophils and basophil granulocytes which can cause severe
damage to the parasites through oxidation of proteins, lipids, and
nucleic acids. Filarial parasites have elaborated a number of antiox
idant mechanisms and are known to effectively evade oxidative
stress mediated by ROS [9,10]. It has been demonstrated that for the
distantly related non-parasitic nematode, Caenorhabditis elegans,
the critical pathway for dealing with oxidative stress, detoxifica
tion of xenobiotics as well as innate immunity, involves a protein
kinase called PMK-1 [12-14]. PMK-1 is a C. elegans ortholog of the
human stress-activated protein kinase p38 (p38), and a member of
the mitogen-activated protein kinase (MAPK) superfamily. Human
p38 is a serine/threonine protein kinase, consisting of four isoforms
(p38a, |3, 7 and 8 ) that play important roles in cellular responses
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Fig. 1. Clustal W alignm ent of hum an and nem atode p38 MAPK catalytic domains. Highly conserved segm ents are highlighted in grey. Roman numerals indicate MAPK subdo
main regions. TheTGY dual phosphorylation m otif is highlighted in bold font (arrow). The corresponding accession num bers are: Brugia malayi: Bm-MPKl. A8PQS0; Wuchereria
bancrofti CMGC/MAPK/p38 protein kinase, WUBG_01668.1/WUBG14523.1(Broad Institute Filarial Database): Loa loa CMGC/MAPK/p38 protein kinase, LOAG.06056.1 (Broad
Institute Filarial Database); Caenorhabditis elegans PMK-1, Q17446; Human p38a (MAPK14), Q16539; E. multicularis EmMPK2, B1VK39.

to external stress signals including osmotic stress, viral infection,
ultraviolet light, heat, and inflammatory cytokines [15]. Activation
of upstream kinases, such as apoptosis signal-regulating kinase 1
(ASK-1), in response to stress leads to the activation of mitogenactivated protein kinase kinases 3 and 6 (MKK3 and MKK6 ) which
dually phosphorylate the TGY motif within the phosphorylation
lip of p38, leading to its activation. Activated p38 subsequently
phosphorylâtes and activates several downstream protein kinases
and transcription factors involved in the regulation of genes that
mediate a variety of anti-stress responses [15]. Similarly, PMK-1
is activated by dual phosphorylation of a TGY motif by SEK-1, an
ortholog of MKK6, in turn leading to the phosphorylation of SKN1 , a transcription factor involved in mesendodermal specification
and oxidative stress responses [12,16]. In this study, we report for
the first time the characterization of a closely related p38/PMK1 ortholog expressed in the filarial parasite, B. malayi, which we
termed Bm-MPKl. Bm-MPKl orthologs are present in other filarial
parasites such as W. bancrofti and L. loa as well as other, non-filarial
parasites, such as Echinococcus multilocularis (Fig. 1). Bm-MPKl
and its orthologs exhibit the characteristic 12 domain structure of
the mitogen-activated protein kinase family as well as the highly
conserved TGY activation motif in domain VIII (Fig. 1). It should
be noted that protozoal parasite protein kinases, including stressactivated protein kinases, have been receiving significant attention
as potential therapeutic targets [17].

2.

Materials and methods

2.1. Generation o f vectors expressing Bm-MPKl

The full length Bm-MPKl sequence was obtained from the
UniProt protein database (EMBL-EBI accession no. A8PQS0). The
human codon-optimized bm-MPKl gene was produced syntheti
cally (Blue Heron Biotechnology, Bothell, WA) and cloned into the
Gateway® system pDONR™221 entry vector (Invitrogen, Carls
bad, CA). The bm-MPIO gene was initially cloned into plasmid
pDONR™221 and then transferred into a pDEST™27 mam
malian expression vector using in vitro LR recombination reaction
as per the manufacturer’s instructions, ultimately producing
Bm-MPKl/pDEST™27. The pDEST™27 vector is an N-terminal
Glutathione S-transferase (GST) fusion vector that generates an
N-terminal GST tagged protein. Plasmid DNA concentration was
determined using Hoechst 33258 dye assay [18].
2.2. Expression o f recombinant Bm-MPI<1

Freestyle™ 293-F cells (HEK 293F, Invitrogen) were maintained
in 125 mL polycarbonate Erlenmeyer flasks containing Freestyle™
293 expression medium (Invitrogen) in a 37 C humidified incu
bator on an orbital shaker platform (135 rpm) with 8% C02. Cells
were subcultured once the cell density reached 2-3 x 106 viable
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cells/mL ensuring >90% cell viability for all experiments. The cell
density and the viability of cells were determined by counting the
cells using the trypan blue exclusion method [19]. Cells were trans
fected with the Bm-MPKl/pDEST™27 expression vector using
Freestyle™ 293fectin Reagent (Invitrogen) or Freestyle™ MAX
Reagent (Invitrogen) according to the manufacturer’s directions.
Forty-eight hours later. HEK 293F cells were treated with 400 p,M
sodium arsenate (Na2HAs04, MP Biomedicals, Solon, Ohio) for 3 h
to activate recombinant Bm-MPKl [20]. Transfected cells were
centrifuged at 100 x g for 5 min and washed twice in cold phos
phate buffered saline (PBS) prior to being lysed in 2.0 mL of cold
lysis buffer [10 mM HEPES pH 7.4, 50 mM 0-glycerolphosphate,
1% Triton X-100, 10% glycerol, 2mM EDTA, 2mM EGTA, 1 mM
DTT, lOmM NaF and 1:100 Halt™ Protease Inhibitor Cocktail
(Thermo-Fisher Scientific, Rockford, IL)] for every 50-100 x lO 6
cells. Alternatively, 1.0 mL of commercial M-PER® Mammalian
Protein Extraction Reagent (Thermo-Fisher Scientific) per 100 mg
(-1 0 0 p,L) of cell pellet with 1:100 Halt™ Protease Inhibitor Cock
tail (Thermo-Fisher Scientific) was used. Cell-free lysates were
clarified by centrifugation at 14,000x g for 10 min prior to use.
Negative control lysates were prepared from cells transfected with
pDEST™27.
2.3. Purification of GST-tagged Bm-MPKl

GST-tagged Bm-MPKl was purified at 4°C using HighAffinity
GST Resin (0.5-1.OmL resin, GenScript, Piscataway, NJ) in a small
column. The column was equilibrated with 10 resin bed volumes
of PBS. Cell lysates were added to the GST resin which was re
suspended and incubated for 1 h with mixing on a tube rotator to
allow protein binding. The column was washed 4 times with 2 mL
of PBS and fractions were monitored by absorbance at 280 nm. The
column was washed once with 2 mL of buffer A (25 mM HEPES,
150 mM NaCl, 1 mM DTT, 10% glycerol, 0.1 mM EDTA, 1:100 Halt™
Protease Inhibitor Cocktail). Protein was eluted with 5 resin bed vol
umes of buffer A supplemented with 10 mM reduced L-glutathione
(Sigma-Aldrich, St. Louis, MO). Fractions were analyzed for pro
tein using the Bradford assay (Sigma-Aldrich), according to the
manufacturer’s instructions, with bovine serum albumin (BSA) as
a standard.
2.4. SDS-PAGE and Western blotting o f Bm-MPKl protein

Bm-MPKl protein samples were analyzed using SDS gel elec
trophoresis (SDS-PAGE). Samples were prepared in NuPAGE® SDS
Sample Buffer (Invitrogen) containing NuPAGE® Reducing Agent
(Invitrogen) and incubated at 90 °C for 5 min prior to loading them
on a NuPAGE® 4-12% Bis-Tris gel (Invitrogen). Gels were run at
constant voltage (200 V) for 40 min in MOPS-SDS running buffer
(Invitrogen) using Novex® Sharp Pre-Stained Protein Standards
(Invitrogen) or MagicMark™ XP Western Standard (Invitrogen)
molecular weight markers. Gels were stained for 1 h with stain
ing solution (0.05% Coomassie Blue R-250, 5% acetic acid, 44%
methanol) and destained with a 50% m ethanol-10% acetic acid
solution for 30 min followed by a 1 h incubation in 5% acetic acid.
Protein was transferred from SDS-PAGE gels on to polyvinylidenefluoride (PVDF) membrane using NuPAGE® Transfer Buffer
(Invitrogen) containing 10% methanol and 0.25% SDS using a
TE77XP Semi-Dry Blotter (Hoefer, Holliston, MA) for 1 h at 54mA
per blot. After transfer, membranes were placed in blocking solu
tion [5% non-fat dry milk in Tris-buffered saline and 0.05% Tween®
20 (TBST)] for 1 h. Blots were either incubated with goat antiGST primary antibody (1:1000 dilution, GE Healthcare, Piscataway,
NJ) or with rabbit Anti-Active® (pTGpY) polyclonal IgG antibody
(1:2000, Promega, Madison, WI) in TBST containing 1.0 mg/mL BSA
and 0.01% sodium azide for 1 h. Membranes were then washed 3

times for 5 min with TBST and incubated for 1 h with alkaline phos
phatase (AP)-linked secondary antibody. The secondary antibodies
used were 1:5000 mouse anti-goat (Santa Cruz Biotechnology,
Santa Cruz, CA) or 1:30,000 anti-rabbit (Sigma-Aldrich) when used
in conjunction with the anti-GST primary antibody or the AntiActive® p38 rabbit polyclonal IgG antibody, respectively. Bm-MPKl
was detected using 2.0 mL of Chromogenic Western Blue® Stabi
lized Substrate for AP (Promega).
2.5. p38 inhibitors
Human p38 inhibitors BIRB796 (Axon, Groningen, Netherlands),
SB203580 (Selleck, Houston, TX) and RWJ67657 ([21] Dr. Fina
Liotta, Montclair State University) were dissolved in 100% DMSO
and stored at - 2 0 C prior to use.
2.6. Bm-MPKl kinase assays
2.6.1. [y -32P] ATP assay

Bm-MPKl protein kinase activity was assayed by monitoring
the incorporation of 32P from [y - 32P] ATP into myelin basic protein
(MBP). Alternatively, Bm-MPKl autophosphorylation was exam
ined in the absence of MBP. Activated Bm-MPKl (0.48 |xM) was
incubated with or without 1.0 p,g of MBP in 20 p,L containing 15 mM
HEPES, (pH 7.4), 2 5 mM (3-glycerophosphate, 15mM NaCl, lOmM
MgCl2, 1 mM EGTA, and 0.02% Tween® 20. Samples were pre
incubated for 10min at 37 °C prior to adding the ATP (50|xM,
0.4p,Ci/p,L [,v-32P] ATP). Following incubation at 37 °C for 2 0 min,
reactions were terminated by adding NuPAGE® SDS sample buffer
(Invitrogen) and subjected to SDS-PAGE as described above. Gels
were stained, destained and dried onto blotting paper (Sigma)
using a vacuum gel dryer prior to performing autoradiography
using Kodak™ BioMax® Maximum Resolution film. Autoradio
graphs were analyzed using Image-J software [22].
2.6.2. IMAP Bm-MPKl kinase assay

Bm-MPKl kinase activity was also assayed using the immo
bilized metal ion affinity-based fluorescence polarization (IMAP,
Molecular Devices, Silicon Valley, CA) assay according to the man
ufacturer’s instructions, in the presence of 100 p,M ATP, 1.0 mM
DTT and where indicated, MKK6 (Sigma-Aldrich) and Bm-MPKl
(un-activated or activated) in reaction buffer - Tween-20 [10 mM
Tris-HCl, pH 7.2,10 mM MgCl2, 0.05% NaN3, and 0.01 %Tween®20
(RB-T), Molecular Devices]. Reactions were initiated with addi
tion of 100-200 nM fluorescent substrate (FAM-p38tide, Molecular
Devices), prepared in RB-T buffer. The fluorescent polarization was
read in parallel and perpendicular with an excitation wavelength
of485 nm and an emission wavelength of 528 nm using a Synergy 2
Microplate reader (BioTek, Winooski, VT). Dose-response inhibitor
assays were conducted as described above using 160ng/well of
sodium arsenate-activated Bm-MPKl or 50ng/well of commer
cial p38a (Millipore, Temecula, CA). The data was analyzed using
four parameter logistic curve using Microsoft Excel Solver and dose
response curves were generated using Microsoft Excel.
2.7. B. malayi culture, p38 inhibitor treatment and phenotypic
analysis
2.7.1. Parasite motility
Female adult B. malayi parasites, harvested from infected jirds,

were procured from the N1AID/N1H Filariasis Research Reagent
Resource Center (FR3). Adult worms were plated in 24-well plates
with 2mL of Advanced RPMI 1640 medium (Invitrogen) sup
plemented with 25 mM HEPES, 2 mM L-Glutamine (Invitrogen),
100 U/mL Penicillin (Invitrogen), 100 p,g/mL Streptomycin (Invitro
gen), 2.5 fjig/mL Amphotericin B solution (Invitrogen), and 5% heat
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inactivated fetal bovine serum and placed in a 37 °C humidified
incubator with 5%C02. After 24 h, adult worms were selected based
upon microfilariae release. Microfilariae release was scored as fol
lows: ( - ) no microfilariae, (±) some microfilariae, (+) moderate
levels of microfilariae, (++) and (+++) if the parasite secrets large
quantities of microfilariae. After the parasites were scored, 6-9
worms were selected for each treatm ent group based on microfi
lariae release and were transferred to new plates. The microfilariae
released in the old plate were pooled together, briefly centrifuged at
5000 x g for 5 min, and re-suspended in 2 mL of media. Microfilarial density was determined using a hemocytometer and plated in a
96-well plate, 80 microfilariae/well with 200 p,Lof complete media.
Treatment groups received the p38 inhibitor, B1RB796 (1 |xM or
10 p.M), 5 mM sodium arsenate with 1 p,M or 10 p.M B1RB796,0.1%
DMSO (control) or 5mM sodium arsenate vehicle control. Cul
tures were placed in a 37 °C humidified incubator with 5% C02.
The worms were transferred into a new plate containing fresh
media and drug every 48 h. Parasite and microfilariae motility were
given a score from 0 to 4 with 4, rapid movement and largely
coiled: 3, moderated movement and uncoiled; 2, slow movement
and uncoiled: 1, twitching movement and uncoiled; 0, no motility
(dead). The motility of the worms and microfilariae were observed
every 24 h and analyzed by a one sided unpaired Student’s t-test
using Microsoft Excel. All experiments were performed 2-3 times
with similar results.
2.7.2. MTT viability assay
Viability was also assessed colorimetrically using 3-(4,5dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT).
The assay was performed as described previously [23] with minor
modifications. Briefly, worms were individually placed into a 96well plate containing 180 p,L of PBS, then 20 |xL of a MTT solution
(5mg/mL in PBS) was added and the plate incubated at 37 °C for
30 min. All the solution was removed from the wells and 200 p,L
of DMSO was then added to the plate. The plate was incubated at
37 °C for 15 min and then placed on a shaker at room temperature
for another 15 min. The absorbance of each sample was measured
at 550 nm.

3. Results
3.1. Enzymatic activity of recombinant Bm-MPKl using a
fluorescently labeled substrate

Bm-MPKl was successfully expressed as a GST-tagged protein
in human HEK 293F cells. As mentioned previously, p38 MAPKs
require activation by dual-phosphorylation of the TGY motif by
upstream kinases [15]. All isoforms of human p38 MAP kinase have
been shown to be activated by MKK6 [24]. Given the high degree of
Bm-MPKl sequence similarity to other p38 kinases and a conserved
TGY motif (Fig. 1), we tested the ability of the upstream kinase acti
vator of human p38, MKK6, to activate Bm-MPKl. Data obtained
using the IMAP assay showed that Bm-MPKl had very low kinase
activity unless it was pre-incubated in the presence of active human
MKK6 (Fig. 2A). Under the conditions of the assay, a concentrationdependent increase in Bm-MPKl kinase activity was observed. The
addition of the potent p38 kinase inhibitor, RWJ67657 [21] to the
assay resulted in virtually complete inhibition of kinase activity
(Fig. 2A). We further tested w hether Bm-MPKl could be activated
by subjecting HEK 293F cells to sodium arsenate-induced oxida
tive stress, which generates reactive oxygen species. Mammalian
proteins comprising the p38 pathway have been shown to be
effectively activated using this approach [20], Sodium arsenateinduced oxidative stress led to a dramatic activation of Bm-MPKl
(Fig. 2B). The addition of recombinant MKK6 to the reaction pro-
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Fig. 2. IMAP Fluorescence Polarization assay of untreated and sodium arsenateactivated Bm-MPKl. The fluorescence polarization response is given as mP and
is a m easure of the change in substrate polarization due to phosphorylation. (A)
Activation of Bm-MPKl purified from Bm-MPKl/pDEST™27-transfected HEK 293-F
cells by incubation in the presence (■) or absence (♦) of MKK6. (B) Bm-MPKl puri
fied from Bm-MPK1/pDEST™27-transfected HEK 293-F cells treated w ith 400 p.M
sodium arsenate for 3 h prior to harvesting the cells. Sodium arsenate-activated BmMPKl incubated in the presence (■) or absence (♦) of MKK6. In both (A) and (B),
sodium arsenate-activated Bm-MPKl treated w ith 10 p,M p38 inhibitor RWJ67657
( • ) or MKK6-activated Bm-MPKl treated w ith 10 p.M p38 inhibitor RWJ67657 ( a )
is also shown. The data was corrected for the blank (buffer only).

vided an additional, small, increase in kinase activity indicating
that arsenate-induced oxidative stress leads to effective activation
of Bm-MPKl. As before, the addition of the human p38 inhibitor,
RWJ67657, effectively inhibited kinase activity (Fig. 2(B)). These
results illustrate the highly conserved nature of nematode and
human p38 kinases both in terms of their mechanism of activation
as well as susceptibility to inhibition.
We next examined w hether activation of Bm-MPKl by oxida
tive stress results in dual phosphorylation of the TGY activation
loop using a polyclonal Anti-Active® p38 antibody that specifi
cally reacts against pTGpY motif in human p38. Western blots of
purified Bm-MPKl from sodium arsenate stressed HEK 293F cells
showed increased phosphorylation compared to unstressed cells
(Fig. 3A). An anti-GST antibody showed equivalent amounts of a
67kDa immunoreactive band in all lanes (Fig. 3B), confirming that
oxidative stress enhances phosphorylation. Moreover, these results
further attest to the highly conserved nature of the TGY motif
between human and B. malayi p38 MAPKs.
3.2. Enzymatic activity of Bm-MPKl using [y -32P]ATP
The IMAP assay for p38 in the previous experiments utilizes a
peptide substrate. We next determined the ability of Bm-MPKl
to phosphorylate a generic MAPK substrate, myelin basic protein
(MBP) using [,y-32P]ATP. Bm-MPKl was capable of efficiently phosphorylating the 20 kDa MBP protein (Fig. 4, lane 3). Also, Bm-MPKl
was found to be capable of autophosphorylation indicated by the
appearance of a radioactive band with a molecular weight of 67 kDa
(Fig. 4, lane 2). Auto-phosphorylation is a common property of a
number of MAPKs.
The effects of two p38 inhibitors exhibiting two distinct
inhibitory mechanisms, BIRB796 [25] and RWJ67657 [21], were
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Fig. 3. Dual phosphorylation of the TGY m otif in Bm-MPKl by arsenate-induced
oxidative stress. (A) W estern blot developed w ith Anti-Active® p38 (pTGpY) rab
bit polyclonal antibody. (B) W estern blot developed w ith anti-GST goat antibody.
Bm-MPKl was expressed in HEK 293-F cells subjected to sodium arsenate-induced
stress. Lane 1, Molecular w eight markers; Lane 2. purified Bm-MPKl (100 ng)
from control cells; and Lane 3, purified Bm-MPKl (100 ng) from sodium arsenate
(As = Na2HAs04)-stressed cells.

next examined. BIRB796 is a potent allosteric inhibitor active
against all isoforms of human p38 [26]. RWJ67657 is a specific class
of human p38 inhibitor that competes with ATP for the occupancy
of the nucleotide binding domain of only p38a and (3 isoforms [21 ].
Ten micromolar B1RB796 inhibited Bm-MPKl activity by 94% while
10 |aM RWJ67657 only inhibited its activity by 61 %(Fig. 5). The one
micromolar B1RB796 inhibited Bm-MPKl activity 73% while 1 p,M
RWJ67657 inhibited Bm-MPKl 73%. In addition, both inhibitors
inhibited Bm-MPKl autophophorylation (Fig. 5).
3.3. Comparison ofp38 inhibitors dose responses for human p38
and Bm-MPKl

We next determined the relative potency of a small panel of p38
inhibitors against Bm-MPKl and human p38 using the IMAP assay.
To this end, dose response curves were generated for the ATP com-

Fig. 5. Inhibition of Bm-MPKl w ith p38 inhibitors B1RB796 and RWJ67657. Myelin
Basic Protein (MBP) was incubated w ith [7 -32P]ATP in the absence and presence of
Bm-MPKl at 3 7 r C for 20 min. The reaction was term inated by the addition of SDS
sample buffer and the reaction m ixture w as subjected to SDS-PAGE. (A) Phospho
rylation was detected by autoradiography. (B) Bands from (A) w ere scanned using
lmagej program and the area under the curve (AUC) calculated from pixel intensity.
Lane 1, control, no inhibitor; Lane 2,1 p,M BIRB796; Lane 3, 10 p.M B1RB796; Lane
4,1 (xM RWJ67657; and Lane 5 .1 0 p.M RWJ67657. The percent inhibition was cal
culated based on control and is indicated in parenthesis. The gel was scanned using
lm agej three times. The bars represent m ean ± SD.

petitive p38 inhibitors, SB203580 [27] and RWJ67657 and for the
allosteric inhibitor B1RB796. The relative potency of these inhibitors
was assessed by determining the half maximal inhibitory concen
tration (IC5o) for each inhibitor. SB203580, RWJ67657 and BIRB796
exhibited IC50 values of 218,121 and 141 nM, respectively, against
Bm-MPKl. The inhibitors each had much greater potency against
human p38, having IC50 values of 33.5, 4.5 and 35.4nM, respec
tively (Fig. 6 and Table 1), suggesting the existence of differences in
the architecture of the inhibitor binding sites between the MAPKs.
Nonetheless, these compounds are well within the sub-micromolar
range for inhibition making them very attractive precursors for the
development of more potent and selective Bm-MPKl inhibitors.
3.4. Effects ofp38 inhibitors on B. malayi stress responses

It is well documented that filarial parasites are highly resistant
to oxidative stress [9,10], therefore we tested whether Bm-MPKl
Table 1
Comparison of relative potency of p38 inhibitors against p38 and Bm-MPKl.
Compound

Fig. 4. Phosphorylation of Myelin Basic Protein (MBP) by Bm-MPKl. MBP was incu
bated w ith [-y-32P]ATP in the absence and presence of Bm-MPKl at 37 C for 20 min.
The reaction was term inated by the addition of SDS sample buffer and subjected to
SDS-PAGE. Phosphorylation was detected by autoradiography. Lane 1, [-y-32P]ATP
and MBP; Lane 2, [7 -32P]ATP and Bm-MPKl; and Lane 3, [7 -32P]ATP, MBP, and
Bm-MPKl.

SB203580
RWJ67657
B1RB796

Ratio

IC50 (nM)
p38

Bm-MPKl

33.5 ± 10.6(5)
4.5 ± 2.1 (2)
35.4 ± 14.0 (4)

218 ± 54.8 (4)
121 ± 1.5(2)
141 ± 44.7 (4)

The data is represented
(count) ± standard error.
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Fig. 7. Effects of sodium arsenate-induced oxidative stress on adult B. malayi m otil
ity in the presence or absence of B1RB796. Female w orm s were cultured w ith
0.1% DMSO (control), 1 pM B1RB796,10 pM B1RB796, 5 mM sodium arsenate alone,
5 mM sodium arsenate w ith 1 pM BIRB796 and 5 mM sodium arsenate w ith 10 pM
B1RB796 for 6 days. Parasite motility was observed every 24 h and a score 0 -4 was
given: *p < 0.01, *” p < 0.0001 by a one-tailed unpaired Student’s t-test using sodium
arsenate as a vehicle control for sodium arsenate w ith B1RB796 and 0.1% DMSO as
a vehicle control for BIRB796 and sodium arsenate alone, n = 5 or 6 worms. Bars
represent mean ± SD.

Fig. 6. Human p38 inhibitor dose-response analysis for p38 and Bm-MPKl. (A) Inhi
bition of hum an p38 activity by SB203580 ( • ) , RWJ67657 ( a ), or BIRB796 (□). (B)
Inhibition of Bm-MPKl activity by SB203580 ( • ) , RWJ67657 ( a ), or B1RB796 (D).

plays a role in protecting B. malayi from oxidative stress using
BIRB796. This particular human p38 inhibitor was selected because
of its potency and high selectivity against all human p38 isoforms
[25,26]. In preliminary experiments we determined that BIRB796
exhibited pronounced effects on parasite motility, an established
measure of parasite viability [28], at drug concentrations exceeding
10 (JiM (data not shown). The relevance of direct effects of BIRB796
on B. malayi motility is unclear. The lack of a defined dose-response
may indicate off target effects at high drug concentrations. Drug
uptake and distribution in parasitic nematodes is complex and not
well defined [29] and the actual concentration of BIRB796 within
the parasite is unknown. Upon establishing a concentration of
BIRB796 that did not affect motility, we determined whether the
combination of 10 p,M BIRB796 and 5 mM sodium arsenate affected
B. malayi motility. Similar to C. elegans, B. malayi are largely resis
tant to oxidative stress induced with 5mM sodium arsenate ([12]
and Fig. 7). Interestingly, the combination of 10|xM BIRB796 and
5mM sodium arsenate resulted in a dramatic decrease in para
site motility by 88% compared to control (Fig. 7). Additionally, B.
malayi parasites were also subjected to an MTT assay to determine
whether the viability of the parasites on day 6 would correspond to
the observed decrease in motility. Addition of 10 |xM BIRB796 and
5 mM sodium arsenate reduced the viability of the parasite by >84%,
confirming the relationship between parasite motility and viability
(Fig. 8). These results support the notion that Bm-MPKl, like the C.
elegans ortholog PMK-1, plays a role in protecting B. malayi from
toxic oxidative stress.
We next examined the effects of BIRB796 on the ability of micro
filariae to respond to oxidative stress induced by sodium arsenate.
Microfilariae are significantly more sensitive to arsenate-induced
oxidative stress than adult worms (Fig. 9). This is consistent with
observations made by others where microfilariae were shown to

0.1%
DMSO

BIRB796
1 pM

BIRB796 As 5 mM As 5 mM + As 5 mM +
10 pM
BIRB796 BIRB796
1 pM
10pM

Fig. 8. Effects of BIRB796 on adult B. malayi responses to arsenate-induced oxida
tive stress as assessed by MTT assay on day 6. Female adult w orm s w ere cultured
w ith 0.1% DMSO (control), 1 pM and 10 pM BIRB796, 5mM sodium arsenate and
5 mM sodium arsenate w ith 1 pM or 10 pM B1RB796 for 6 days: ***p< 0.0001 by a
one-tailed unpaired Student’s t-test using sodium arsenate as a vehicle control for
sodium arsenate w ith 1 pM or 10 pM B1RB796 and 0.1% DMSO as a vehicle control
for BIRB796 and sodium arsenate alone. n = 2 -9 w orms. Bars represent m e a n iS D .

0.1% DMSO

BIRB796 10 pM

As 5 mM

As5m M +
B1RB796 10 pM

Fig. 9. Effects of BIRB796 on B. malayi microfilariae motility under sodium arsenateinduced oxidative stress. Microfilariae (80 microfilariae/well) w ere cultured w ith
0.1% DMSO (control), 10 pM BIRB796, 5mM sodium arsenate, and 5mM sodium
arsenate w ith 10 pM B1RB796 for 6 days in a 96-well plate. The motility of the micro
filariae w ere observed every 24 h and a score 0 -4 was given: *p<0.01, ***p < 0.0001
by a one sided unpaired Student’s t-test using sodium arsenate as a vehicle control
for sodium arsenate w ith 10 pM B1RB796 and 0.1% DMSO as a vehicle control for
B1RB796 and sodium arsenate alone, n = 6 wells. Bars represent mean ± SD.
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be more sensititive to oxidative stress induced with hydrogen per
oxide [11]. Over the course of 6 days, a significant reduction in
microfilarial motility was observed in the presence of 5 mM sodium
arsenate. Addition of 10p.M BIRB796 resulted in a statistically
significant reduction in motility over w hat was observed with treat
ment with sodium arsenate alone (Fig. 9). These results indicate
that, Bm-MPKl plays a role in microfilarial responses to ROS.

4. Discussion
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This paper describes the biochemical characterization of a
B. malayi stress-activated p38/PMK-l kinase ortholog Bm-MPKl

along with an analysis of the effects of p38 inhibitors on Bm-MPKl
kinase activity and on the ability of B. malayi to respond to ROS. BmMPKl is highly homologous to C. elegans PMK-1 which is known to
play a critical role in protection against oxidative stress and innate
immunity [12-14], Genetic deletion of PMK-1, or its upstream acti
vator SEK-1, attenuates C. elegans responses to oxidative stress
induced by sodium arsenate [12]. Tissue dwelling filarial parasites
such as the lymphatic parasites W. bancrofti and B. malayi and
cutaneous 0. volvulus strongly modulate host immune responses
through several mechanisms [7-9]. These organisms tend to be
long lived in their hosts and as such, must deal with host immune
responses to avoid elimination while sparing the host from severe,
life threatening pathology. An early first line of defense against
parasitic infection is the generation of reactive oxygen and nitro
gen species (RNS) by macrophages and granulocytes [30]. ROS
represents a class of highly reactive chemical species such as super
oxide anion (02~) that are formed in these cells through the action
of NADPH oxidase [31]. B. malayi, like other parasites, produces
several secreted and non-secreted enzymes such as superoxide dismutase (SOD), thioredoxin peroxidase and glutathione peroxidase
for defense against oxidative damage [30].
The biochemistry of nematode anti-oxidation mechanisms has
been extensively studied in the free-living nematode, C. elegans.
It has been shown in C. elegans that a mitogen-activated pro
tein kinase pathway (MAPK) is critically important for regulating
responses to oxidative stress as well as xenobiotic detoxification
and innate immunity [12,13]. In response to oxidative stress, C. ele
gans PMK-1 kinase, an ortholog of human p38 kinase, is activated
and directly phosphorylates SKN-1, a transcription factor impor
tant for embryonic mesendodermal development and regulation
of oxidative stress responses in the adult (16). Phosphorylation of
SKN-1 by PMK-1 results in the translocation of SKN-1 into intesti
nal nuclei where it functions in the regulation of the expression
of a variety of antioxidant and phase II detoxification genes such
as SOD [16]. Regulation of SKN-1 transcriptional activity through
phosphorylation is likely to be more complex since, in addition to
PMK-1, it is a substrate for at least four additional protein kinases
[32]. Unlike C. elegans, little is known regarding the biochemical
and molecular details of the regulation of anti-oxidative responses
in parasitic nematodes. In the study presented here, we have char
acterized a PMK-1 /p38 ortholog, Bm-MPKl, from the human filarial
parasite, B. malayi. Using a chemical biological approach, we have
demonstrated inhibition of Bm-MPKl activity with known ATP
competitive and allosteric p38 inhibitors. Furthermore, we have
demonstrated that the potent allosteric p38 inhibitor, BIRB796,
suppresses B. malayi anti-oxidative responses to ROS induced by
sodium arsenate. We have also shown that treatm ent of adult
female worms with BIRB796, under oxidative stress conditions,
results in death of the parasites. Additional studies are underway to
determine the effects of BIRB796 on stress responses in other devel
opmental stages of B. malayi, especially L3 larvae, the infectious
larval form of B. malayi introduced into the host from a mosquito
vector.

Fig. 10. Comparison of B. malayi Bm-MPKl and C. elegans PMK-1 stress-activated
signaling pathways.

The B. malayi Bm-MPKl pathway shares several similarities to
the C. elegans PMK-1 pathway (Fig. 10) including the presence of
orthologs of upstream activating protein kinases such as SEK-1 [5].
However, there are also differences such as the apparent absence of
an SKN-1 ortholog in B. malayi [33]. Additional studies are under
way in our laboratory to further define this pathway. One important
aspect of this work is the use of chemical probes to study para
sitic nematode signaling pathways. Unlike C. elegans and protozoal
parasites, filarial parasites are frequently resistant to manipulation
using standard molecular genetics approaches such as RNAi [34,35].
Synthetic inhibitors, therefore, provide an alternative, chemical
biological, approach to study gene function in these organisms.
Our results, in addition to defining the biochemical mechanisms
involved in parasitic nematode responses to oxidative stress, may
offer a potential strategy for treating filarial disease. The design of
highly selective and potent Bm-MPKl inhibitors could potentially
be used to interfere with Bm-MPKl induction of drug detoxification
genes such as gamma-glutamylcysteine synthetase (gcs-1) which
catalyzes the first, rate-limiting step in the biosynthesis of glu
tathione (GSH). C. elegans (GCS-1), is known to be regulated through
the PMK-1/SKN-1 pathway and plays a role in resistance to oxida
tive stress in this organism [12]. Mentioned earlier, GSH, along
with GST, glutathione peroxidase (GP) and glutathione reductase
(GR), constitute an important antioxidant system in filarial par
asites contributing to their long-term survival in the host [30].
Filarial parasite GST has been targeted for the development of
anti-parasitic drugs [36,37]. Disruption of this pathway with BmMPKl inhibitors may compromise the ability of filarial parasites to
counteract host oxidative stress responses. In addition, the poten
tial detoxification of known anti-filarial drugs by conjugation with
reduced glutathione through the action of GST may be attenuated
allowing for an increase in potency and efficacy of known antiparasitic drugs. In conclusion, we have demonstrated, through a
chemical biological approach, that the B. malayi stress-activated
MAPK, Bm-MPKl, functions in a signaling pathway important for
parasite anti-oxidative responses to ROS. The presence of highly
homologous Bm-MPKl orthologs in other filarial and non-filarial
parasites indicates a similar role for these kinases in anti-oxidative
and detoxification processes. Further characterization of this path
way will provide additional insights into filarial parasite responses
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to host-generated ROS and the therapeutic potential of inhibiting
this response.
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